S Persiani
Overview
    Explore the profile of S Persiani including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              29
            
            
              Citations
              360
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Clauser P, Dolciami M, Grassi F, DAmario A, Persiani S, Celli V, et al.
  
  
    Eur J Radiol
    . 2025 Jan;
          183:111926.
    
    PMID: 39826155
  
  
          Pathologies of the vulva encompass a wide range of mesenchymal and epithelial benign and malignant lesions. Suspicion is raised by non-specific symptoms or clinical findings detected during routine gynecological examinations,...
      
2.
        
    
    Debroy S, Hiraga N, Imamura M, Hayes C, Akamatsu S, Canini L, et al.
  
  
    J Viral Hepat
    . 2016 Jun;
          23(9):708-17.
    
    PMID: 27272497
  
  
          Legalon SIL (SIL) is a chemically hydrophilized version of silibinin, an extract of milk thistle (Silybum marianum) seeds that has exhibited hepatoprotective and antiviral effectiveness against hepatitis C virus (HCV)...
      
3.
        
    
    Persiani S, Sala F, Manzotti C, colovic M, Zangarini M, Donazzolo Y, et al.
  
  
    Drug Res (Stuttg)
    . 2015 Jul;
          66(3):136-40.
    
    PMID: 26125285
  
  
          Background: Post-menopausal women under treatment with levothyroxine for their medical conditions may take concomitantly dietary supplements containing soy isoflavones in combination to treat their post-menopausal symptoms. The aim of this...
      
4.
        
    
    Kraus V, Blanco F, Englund M, Henrotin Y, Lohmander L, Losina E, et al.
  
  
    Osteoarthritis Cartilage
    . 2015 May;
          23(5):686-97.
    
    PMID: 25952342
  
  
          The objective of this work was to describe requirements for inclusion of soluble biomarkers in osteoarthritis (OA) clinical trials and progress toward OA-related biomarker qualification. The Guidelines for Biomarkers Working...
      
5.
        
    
    Kraus V, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, et al.
  
  
    Osteoarthritis Cartilage
    . 2011 Mar;
          19(5):515-42.
    
    PMID: 21396468
  
  
          Objective: Osteoarthritis (OA) is a chronic and slowly progressive disease for which biomarkers may be able to provide a more rapid indication of therapeutic responses to therapy than is currently...
      
6.
        
    
    Pastorini E, Rotini R, Guardigli M, Vecchiotti S, Persiani S, Trisolino G, et al.
  
  
    J Pharm Biomed Anal
    . 2009 Aug;
          50(5):1009-14.
    
    PMID: 19647388
  
  
          A new HPLC method for the determination of glucosamine (2-amino-2-deoxy-D-glucose) in human synovial fluid was developed and validated. Synovial fluid samples were analyzed after a simple protein precipitation step with...
      
7.
        
    
    Persiani S, Rotini R, Trisolino G, Rovati L, Locatelli M, Paganini D, et al.
  
  
    Osteoarthritis Cartilage
    . 2007 Mar;
          15(7):764-72.
    
    PMID: 17353133
  
  
          Objective: We investigated the synovial and plasma glucosamine concentrations in osteoarthritic patients following oral administration of crystalline glucosamine sulphate at the therapeutic dose of 1500mg once-a-day for 14 days. Design:...
      
8.
        
    
    Persiani S, Roda E, Rovati L, Locatelli M, Giacovelli G, Roda A
  
  
    Osteoarthritis Cartilage
    . 2005 Sep;
          13(12):1041-9.
    
    PMID: 16168682
  
  
          Objective: Pharmacokinetic data on glucosamine are scant, limiting the understanding of glucosamine sulfate mechanism of action in support of its treatment effects in osteoarthritis. This study investigated the oral pharmacokinetics...
      
9.
        
    
    Webber C, Stokes C, Persiani S, Makovec F, McBurney A, Kapil R, et al.
  
  
    Eur J Drug Metab Pharmacokinet
    . 2004 May;
          29(1):15-23.
    
    PMID: 15151166
  
  
          Single oral doses of 14C-dexloxiglumide were rapidly and extensively absorbed in dogs and also eliminated rapidly with a short half-life. Following single intravenous doses, dexloxiglumide was characterised as a drug...
      
10.
        
    
    Webber C, Stokes C, Persiani S, Makovec F, McBurney A, Kapil R, et al.
  
  
    Eur J Drug Metab Pharmacokinet
    . 2003 Oct;
          28(3):201-12.
    
    PMID: 14527093
  
  
          Single oral doses of 14C-dexloxiglumide were rapidly and extensively absorbed in rats, and eliminated more slowly by females than by males. The respective half-lives were about 4.9 and 2.1 h....